British scientists found that dementia developed in 5 out of 8 patients who received cadaver-derived growth hormone injections as children in the 1960s to 1980s. Analysis showed that abnormally high levels of Alzheimer's-related amyloid proteins in the brain likely originated from those injections.
The lead researcher, Dr. John Colling, emphasizes that the goal now is to take precautions against any factor, even a secondary and rare one, that may lead to neurodegenerative diseases. If you found an error in the article, we would appreciate it if you shared it with us.